After a 13-year run at FierceBiotech, I’m stepping aside as editor-in-chief of our plucky, global band of life sciences reporters.

Ipsen has strengthened its connection to Oncodesign, the French oncology specialist that lists Bristol-Myers Squibb among its partners.

In this week's EuroBiotech Report, Metabomed celebrated adding Pfizer to a list of investors that already featured the VC units of Merck KGaA and…

Sanofi has poached Dr. Yong-Jun Liu as its new head of research from MedImmune as it looks to beef up its early-stage pipeline and senior R&D…

Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world…

WuXi PharmaTech, China's largest CRO, closed an oversubscribed $290 million venture fund, turning its attention to biopharma startups at home and in…

The head of the U.K.'s Trade & Investment in the Ministry of the same name has begun a three-day visit to India to focus on biotech and health…

In no-holds-barred action, the European Medicines Agency has accused India-based CRO GVK Biosciences of systematically faking clinical trials for about 700…

China biotech Innovent's recent success in raising $100 million in venture capital to help it build a pipeline of biosimilars could be a signal of how…

Outsourcing